Distinct amyloid distribution patterns in amyloid positive subcortical vascular cognitive impairment

[1]  C. Cordonnier,et al.  Sporadic cerebral amyloid angiopathy. , 2019, Geriatrie et psychologie neuropsychiatrie du vieillissement.

[2]  Andreas Charidimou,et al.  MRI-visible perivascular spaces in cerebral amyloid angiopathy and hypertensive arteriopathy , 2017, Neurology.

[3]  Norbert Schuff,et al.  Robust Identification of Alzheimer’s Disease subtypes based on cortical atrophy patterns , 2017, Scientific Reports.

[4]  M. Weiner,et al.  The Role of Cerebrovascular Disease in Amyloid Deposition. , 2016, Journal of Alzheimer's disease : JAD.

[5]  M. Frosch,et al.  Total Magnetic Resonance Imaging Burden of Small Vessel Disease in Cerebral Amyloid Angiopathy: An Imaging-Pathologic Study of Concept Validation. , 2016, JAMA neurology.

[6]  Yoichi Chiba,et al.  Blood–brain barrier and blood–cerebrospinal fluid barrier in normal and pathological conditions , 2016, Brain Tumor Pathology.

[7]  Jeih-San Liow,et al.  Cerebellum Can Serve As a Pseudo-Reference Region in Alzheimer Disease to Detect Neuroinflammation Measured with PET Radioligand Binding to Translocator Protein , 2015, The Journal of Nuclear Medicine.

[8]  Joanna M. Wardlaw,et al.  Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden , 2014, Neurology.

[9]  M. Weiner,et al.  Effects of APOE ɛ4 on brain amyloid, lacunar infarcts, and white matter lesions: a study among patients with subcortical vascular cognitive impairment , 2013, Neurobiology of Aging.

[10]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[11]  Cindee M. Madison,et al.  Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. , 2013, Brain : a journal of neurology.

[12]  L. Launer,et al.  Midlife Blood Pressure, Plasma &bgr;-Amyloid, and the Risk for Alzheimer Disease: The Honolulu Asia Aging Study , 2012, Hypertension.

[13]  B. Zlokovic.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.

[14]  J. S. Kim,et al.  Identification of pure subcortical vascular dementia using 11C-Pittsburgh compound B , 2011, Neurology.

[15]  S. Feske.  Posterior reversible encephalopathy syndrome: a review. , 2011, Seminars in neurology.

[16]  K. Jellinger,et al.  Review: Sporadic cerebral amyloid angiopathy , 2011, Neuropathology and applied neurobiology.

[17]  C. Rowe,et al.  Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging , 2010, Neurobiology of Aging.

[18]  L. Pantoni.  Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges , 2010, The Lancet Neurology.

[19]  Sang Won Seo,et al.  Seoul Neuropsychological Screening Battery-Dementia Version (SNSB-D): A Useful Tool for Assessing and Monitoring Cognitive Impairments in Dementia Patients , 2010, Journal of Korean medical science.

[20]  M. van Buchem,et al.  Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy , 2010, Neurology.

[21]  Karen J. Ferguson,et al.  Enlarged Perivascular Spaces on MRI Are a Feature of Cerebral Small Vessel Disease , 2010, Stroke.

[22]  L. Grinberg,et al.  Vascular pathology in the aged human brain , 2010, Acta Neuropathologica.

[23]  M. Sabbagh,et al.  Intracranial atherosclerosis as a contributing factor to Alzheimer’s disease dementia , 2009, Alzheimer's & Dementia.

[24]  Berislav V. Zlokovic,et al.  Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease , 2009, Acta Neuropathologica.

[25]  Steven Warach,et al.  Cerebral Microbleeds : A Field Guide to their Detection and Interpretation , 2012 .

[26]  G. Lembo,et al.  β-Amyloid deposition in brain is enhanced in mouse models of arterial hypertension , 2009, Neurobiology of Aging.

[27]  C. Jack,et al.  11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. , 2008, Brain : a journal of neurology.

[28]  M. Wiesmann,et al.  Subarachnoid Hemosiderosis and Superficial Cortical Hemosiderosis in Cerebral Amyloid Angiopathy , 2008, American Journal of Neuroradiology.

[29]  Keith A. Johnson,et al.  Imaging of amyloid burden and distribution in cerebral amyloid angiopathy , 2007, Annals of neurology.

[30]  C. Sudlow,et al.  Is hypertension a more frequent risk factor for deep than for lobar supratentorial intracerebral haemorrhage? , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[31]  Karen J. Ferguson,et al.  Enlarged perivascular spaces are associated with cognitive function in healthy elderly men , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[32]  R. Petersen.  Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.

[33]  O. Wiestler,et al.  Vascular Pathology in Alzheimer Disease: Correlation of Cerebral Amyloid Angiopathy and Arteriosclerosis/Lipohyalinosis with Cognitive Decline , 2003, Journal of neuropathology and experimental neurology.

[34]  D. Dickstein,et al.  Blood—Brain Barrier Permeability Precedes Senile Plaque Formation in an Alzheimer Disease Model , 2003 .

[35]  Ann Marie Schmidt,et al.  RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain , 2003, Nature Medicine.

[36]  L. Lipsitz,et al.  The microvascular frontal-subcortical syndrome of aging , 2002, Neurobiology of Aging.

[37]  N. Tzourio-Mazoyer,et al.  Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.

[38]  A. Hofman,et al.  Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study , 1997, The Lancet.

[39]  R. Leiguarda,et al.  Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer's disease. , 1996, Stroke.

[40]  B. Zlokovic,et al.  Blood-brain barrier transport of circulating Alzheimer's amyloid beta. , 1993, Biochemical and biophysical research communications.

[41]  C. Vincent,et al.  Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins. , 1991, Transplantation.

[42]  K. Ogomori,et al.  Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease. , 1989, The American journal of pathology.

[43]  S. Pantelakis.  [A particular type of senile angiopathy of the central nervous system: congophilic angiopathy, topography and frequency]. , 1954, Monatsschrift fur Psychiatrie und Neurologie.

[44]  Stefanos Pantelakis.  Un type particulier d'angiopathie sénile du système nerveux central: l'angiopathie congophile. Topographie et fréquence; pp. 219–237 , 1954 .

[45]  E. Yuliwati,et al.  A Review , 2019, Current Trends and Future Developments on (Bio-) Membranes.

[46]  D. Werring,et al.  White matter hyperintensities are associated with amyloid burden in APOE4 non-carriers. , 2014, Journal of Alzheimer's disease : JAD.

[47]  C. Jack,et al.  11 C PiB and structural MRI provide complementary information in imaging of Alzheimer ’ s disease and amnestic mild cognitive impairment , 2008 .

[48]  J. Saczynski,et al.  The Honolulu-Asia Aging Study , 2007 .

[49]  Henry Brodaty,et al.  Cerebral blood volume in T2-weighted white matter hyperintensities using exogenous contrast based perfusion MRI. , 2004, The Journal of neuropsychiatry and clinical neurosciences.

[50]  K. Jellinger,et al.  Incidence of cerebrovascular lesions in Alzheimer's disease: a postmortem study , 2002, Acta Neuropathologica.

[51]  B. Zlokovic,et al.  Blood-brain barrier transport of circulating Alzheimer's amyloid beta. , 1993, Biochemical and biophysical research communications.